Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Alzheimer's Disease Research - Current Award

Photo Pending

Gerry Shaw, Ph.D.

University of Florida
Gainesville, FL

Title: Blood And CSF Biomarkers Of Alzheimer's Disease
Non-Technical Title: Monitoring Alzheimer's Disease

Acknowledgements: Partially supported by a generous donation from the Kenneth and Ann Reim Trust
Duration: April 1, 2009 - March 31, 2011
Award Type: Pilot
Award Amount: $150,000


Summary:

Alzheimer's disease is difficult to diagnose and it is also difficult to monitor the progression of the disease. We have developed two assays which can be used to monitor neurodegeneration using blood and cerebrospinal fluid (CSF) samples. The aim of the present proposal is to see if these assays can be used to monitor Alzheimer's disease.

Details:

Alzheimer's disease is difficult to diagnose and it is also difficult to monitor the progression of the disease. Monitoring disease progression in a convenient fashion would allow the effectiveness of Alzheimer’s disease therapies to be assessed in individual patients, which might be very beneficial. We have developed two assays which can be used to monitor neurodegeneration using blood and cerebrospinal fluid (CSF) samples. The aim of this project is to see if these assays, and modified assays based on them, can be used to specifically monitor the presence and progression of Alzheimer's disease.